Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Flerie
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
TwoStep11-50 employees
TwoStep Therapeutics. Developing tumor-targeted therapies with broad applicability across solid tumors.
EpiEndo PharmaceuticalsSeries A $21.6M · 5 yr ago
EpiEndo Pharmaceuticals. We are a clinical-stage biopharmaceutical company committed to developing oral drugs for chronic respiratory…
MindpeakFounded 2018 • 11-50 employees • 6 roles
Mindpeak transforms tissue into high-dimensional data, enabling the discovery of AI-driven biomarkers that guide targeted therapies and…
Fore BiotherapeuticsSeries D $67.4M · 3 mo ago • 51-200 employees
Leading the future of targeted therapies for the hardest to treat cancers. Wednesday, October 15, 202512:00 pm ET.
Draupnir BioSeed $13M · 2 yr ago
Draupnir Bio is developing new innovative therapies for patients.
Explore Translational Drug Discovery at Orionis Biosciences to develop targeted therapies and translational platforms. Focused on clinical…

Overview

Buzzard Pharmaceuticals, a clinical-stage biotech company developing innovative IL-1 targeted therapies focused on inflammation-driven diseases.